Every night, the online Belgian patent register ('eRegister') receives an update with public data that were entered or generated the preceding day on the Benelux Patent Platform, the computer application with which the Belgian Intellectual Property Office handles the registration, treatment and publication processes for patents and supplementary protection certificates.
Currently, some updates are spread over consecutive nights due to the large, weekly volume of data concerning European patents designating Belgium.
For a European patent it is possible that data about the inventor(s) are missing from the online Belgian patent register. They can be found via the link to the European patent register pending an update of the Belgian patent register.
For European patents with Unitary Effect, the authentic source of information is the European Patent Register : please refer to it.

Patent details

1480679 Title: FORMULATION PHARMACEUTIQUE D'IRESSA COMPRENANT UN DERIVE DE CELLULOSE SOLUBLE DANS L'EAU

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic information

Application number:
037067329
WO application number:
GB2003000803
Type:
European patent granted for BE
Status:
Expired
Publication number:
1480679
WO publication number:
WO 2003/072139
1rst applicant's nationality:
Translation language:
French
EPO publication language:
English
SPC number:

Dates

Filing date:
24/02/2003
Grant date:
23/05/2007
EP publication date:
WO publication date:
Claims translation received date:
Translation received date (EP publication B1):
25/07/2007
Translation received date (EP publication B2):
Translation received date (EP publication B3):
Registration date:
23/05/2007
EP B1 publication date:
23/05/2007
EP B2 publication date:
EP B3 publication date:
Lapsed date:
Expiration date (if granted and all annual fees paid):
24/02/2023

Applicant

Name:
AstraZeneca AB
Legal Form:
From:
23/05/2007
Address:
Sodertalje, 151 85, -, Sweden (SE)
To:

Agent

1

Name:
OFFICE KIRKPATRICK S.A.
Legal Form:
From:
23/12/2020
Address:
Avenue Wolfers 32, 1310, LA HULPE, Brabant wallon, Belgium (BE)
To:

2

Name:
PLUCKER Guy
Legal Form:
From:
25/07/2007
Address:
Avenue Wolfers 32, 1310, LA HULPE, Belgium (BE)
To:
23/12/2020

Inventor

1

Name:
GELLERT, Paul Richard
Legal Form:
Address:

2

Name:
PARKER, Michael Davis
Legal Form:
Address:

3

Name:
DE MATAS Marcel
Legal Form:
Address:

Priority

1

Priority patent number:
0213267
Priority date:
11/06/2002
Priority country:
United Kingdom (GB)

2

Priority patent number:
0212462
Priority date:
30/05/2002
Priority country:
United Kingdom (GB)

3

Priority patent number:
0204392
Priority date:
26/02/2002
Priority country:
United Kingdom (GB)

Classification

Main IPC class:
A61K 47/38;
IPC or IDT classification:
A61K 31/5377; A61P 35/00;

Publication

Bulletin

1

Bulletin heading:
EP2
Journal edition number:
2007/05
Publication date:
31/05/2007
Description:
Contains data concerning European patents granted and published (B1 publication) for Belgium and for which no translation needed to be filed

2

Bulletin heading:
VRV
Journal edition number:
2023/04
Publication date:
06/03/2023
Description:
Contains data concerning lapse, annulment or rejection of patent(s) (applications) and SPC (applications)

Annual fee

Annual fee(s) Due Date:
Annual fee number:
Expected payer:
Last annual fee payment date:
18/01/2022
Last annual fee paid number:
20
Last annual fee paid amount:
600 Euro
Payer:
C.P.A.
Filing date Document type Publication Type Document Description Number of pages File Type
25/07/2007 General Document (TO - T:Traduction Originale) 65 PDF /9/7/6/0/8/0611480679/migrated-docs/037067329_1_217952.pdf